Search

everythinglearnresearchcommunity

for

Search:↓

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

Ruxolitinib cream effectively treats skin conditions like atopic dermatitis and vitiligo with minimal side effects.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.

Topical ruxolitinib and oral minoxidil together can regrow hair in certain types of hair loss.

Indinavir therapy can cause reversible skin, hair, and nail darkening.

Tacalcitol ointment effectively improves bilateral nevus comedonicus.

These new skin treatments are safer and more effective with minimal side effects.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Certain herbal compounds, especially from bitter melon, can inhibit cancer growth and promote hair growth by blocking PAK1.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Tofacitinib effectively improved hair regrowth and skin condition in a woman with alopecia totalis and lichen planus hypertrophicus.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

Monitoring TGF-β and linc-PINT expression may help identify and treat high-risk heart arrhythmia patients.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.

Ritlecitinib is effective and safe for treating severe alopecia areata, showing significant hair regrowth and improved mental health.

Blocking mTORC1 reduces skin tumor growth in mice.

Patients prefer the higher 50 mg dose of ritlecitinib for better hair regrowth despite higher risks.

Docetaxel is effective against various cancers but mainly causes neutropenia.

Nitroxide drugs can safely and effectively treat age-related diseases like macular degeneration and cardiovascular issues.

The new treatment using tiny lipid carriers to deliver minoxidil and latanoprost directly to hair follicles shows promise for alopecia.

ALRN-6924 may prevent hair loss caused by chemotherapy.